Imdylltra 10 mg, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung

7680691320026 CH-69132 Pulver

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/09/2026
Summary of Product Characteristics
Français
12/09/2026
Summary of Product Characteristics
Italien
12/09/2026

Detailed composition

Substance Quantity Type Category
tarlatamabum
10.0 MG Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
saccharum
- Substance HNIDK
lysini hydrochloridum
- Substance HNIDK
acidum glutamicum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
- Substance HBESI
natrium
12.88 MG Substance HBESI

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
69132
Drug name
Imdylltra, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung
Galenic form
PULPIS
ATC Code
L01FX33
Authorization status
Z
Dispensing category
A
First authorization
08/05/2026
Authorization expiration date
07/05/2031
IT Number
07.16.1.
Domain
Human medicine
Field of application
kleinzelliges Lungenkarzinom

Package details

Description (FR)
IMDYLLTRA poudre pour solution à diluer et solutio
Description (DE)
IMDYLLTRA Pulver zur Herstellung eines Konzentrats
Market launch
08/05/2026
Narcotic (BTM)
No

Other package sizes (1)

IMDYLLTRA poudre pour solution à diluer et solutio
1 DUR
GTIN: 7680691320019
View
Buy us a coffee Explore the data